Read this....then read it again..then really read it again...what do you take from it?
UHP will be submitting final documentsrequested by the FDA in conjunction with its PMA (Class III) application to use HemoStyp in internal surgeries. The company expects the FDA to seek additional information or approve the file within 30 days following the submission of the final documents.
Market Data 
Markets 
AI
